If a bacterial isolate is susceptible to penicillins, can a cephalosporin be used effectively?

Cephalosporins Are Generally Effective Against Penicillin-Susceptible Bacteria

Yes, cephalosporins will work against bacteria susceptible to penicillins, with the important caveat that penicillin susceptibility does not guarantee susceptibility to all cephalosporins, particularly in Streptococcus pneumoniae with intermediate penicillin resistance. 1

General Principle: Penicillin-Susceptible Organisms

• Bacteria fully susceptible to penicillin (MIC ≤0.06 mg/L for oral penicillin in S. pneumoniae) can be considered susceptible to cephalosporins, including oral agents like cefpodoxime and parenteral agents like ceftriaxone. 1

• For group A beta-hemolytic streptococcal (GABHS) tonsillopharyngitis, cephalosporins demonstrate superior bacteriologic cure rates (OR: 3.02) and clinical cure rates (OR: 2.33) compared to penicillin, despite the organism being penicillin-susceptible. 2

Critical Exception: Intermediate Penicillin Resistance

• When bacteria are nonsusceptible to oral penicillin (MIC >0.06 mg/L), susceptibility to oral cephalosporins like cefpodoxime cannot be reliably predicted, with categorical agreement dropping to only 78.4%. 1

• In S. pneumoniae with intermediate penicillin resistance (MIC 0.125-1.0 mg/L), bacteriologic failure rates increase dramatically:

  • 6% failure with fully susceptible organisms 3
  • 21% failure with MIC 0.125-0.25 mg/L 3
  • 64% failure with MIC 0.38-1.0 mg/L 3

• Oral cephalosporins (cefaclor, cefuroxime axetil) show impaired bacteriologic response against intermediately penicillin-resistant pneumococci, with cefaclor performing worse (58% failure) than cefuroxime axetil (21% failure). 3

Cephalosporin Selection Based on Resistance Patterns

For Fully Penicillin-Susceptible Organisms:

• All generations of cephalosporins are effective 1
• First-generation (cephalexin, cefazolin), second-generation (cefuroxime), and third-generation (ceftriaxone, cefotaxime) agents all achieve adequate coverage 4, 2

For Intermediately Resistant S. pneumoniae:

• The most effective cephalosporins are cefuroxime, cefotaxime, and ceftriaxone, with 50% of intermediately resistant strains inhibited by 0.06 mg/mL and 90% by 0.25 mg/mL—concentrations attainable in CSF. 4

• The least effective cephalosporins against intermediately resistant pneumococci are cefaclor, moxalactam, and ceftazidime. 4

• Ceftriaxone MIC can serve as a surrogate for cefpodoxime susceptibility using lower breakpoints (≤0.25 mg/L for susceptible; 0.5 mg/L for intermediate; ≥1 mg/L for resistant). 1

Practical Algorithm for Clinical Decision-Making

1. Confirm penicillin susceptibility status through MIC testing, not just disk diffusion 1

2. If fully penicillin-susceptible (MIC ≤0.06 mg/L):

   • Any cephalosporin is appropriate 1
   • Consider cephalosporins for enhanced bacteriologic cure in GABHS 2

3. If intermediately resistant (MIC >0.06 mg/L):

   • Avoid oral cephalosporins for empiric therapy without specific susceptibility testing 1, 3
   • Prefer parenteral third-generation cephalosporins (ceftriaxone, cefotaxime) over oral agents 4
   • Avoid cefaclor, ceftazidime, and moxalactam 4

4. If cephalosporin MIC >0.5 mg/L:

   • Expect bacteriologic failure regardless of penicillin susceptibility 3

Common Pitfalls to Avoid

• Do not assume that penicillin nonsusceptibility automatically means cephalosporin resistance—the relationship is complex and depends on specific MIC values and the cephalosporin chosen 1, 4

• Do not rely on oxacillin disk diffusion alone for predicting cephalosporin susceptibility; quantitative MIC testing is required 1

• Avoid prescribing oral cephalosporins empirically for community-acquired pneumonia when intermediately penicillin-resistant S. pneumoniae is suspected, as bacteriologic failure rates are unacceptably high 1, 3

• Recognize that resistance patterns have evolved over time, with a trend toward diminishing bacterial cure with penicillin from the 1970s through 1990s 2